Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
The New England Journal of Medicine
|
July 12, 2023
Precision Oncology for Papillary Craniopharyngioma
Jaishri O Blakeley, Kevin Shannon
The Medical Clinics of North America
|
October 5, 2019
The Diagnosis and Management of Neurofibromatosis Type 1
K Ina Ly, Jaishri O Blakeley
Continuum (Minneapolis, Minn.)
|
December 5, 2017
Common Histologically Benign Tumors of the Brain
Roy E Strowd, Jaishri O Blakeley
Neuro-Oncology
|
October 10, 2024
Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib
Scott R Plotkin, Jaishri O Blakeley
Current Treatment Options in Oncology
|
October 13, 2006
Management of pineal region tumors
Jaishri O Blakeley, Stuart A Grossman
Current Neurology and Neuroscience Reports
|
November 22, 2021
Brain Cancers in Genetic Syndromes
Edina Komlodi-Pasztor, Jaishri O Blakeley
Neuro-Oncology
|
February 7, 2016
Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis
Jaishri O Blakeley, Scott R Plotkin
Journal of the Neurological Sciences
|
July 10, 2007
Thrombolytic therapy for acute ischemic stroke
Jaishri O Blakeley, Rafael H Llinas
The British Journal of Dermatology
|
December 20, 2023
Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1
Carlos G Romo, Kavita Y Sarin, Jaishri O Blakeley
Seminars in Oncology
|
May 15, 2016
Cutaneous manifestations in neuro-oncology: clinically relevant tumor and treatment associated dermatologic findings
Roy E Strowd, Lindsay C Strowd, Jaishri O Blakeley
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
The New England Journal of Medicine
|
July 12, 2023
Precision Oncology for Papillary Craniopharyngioma
Jaishri O Blakeley, Kevin Shannon
The Medical Clinics of North America
|
October 5, 2019
The Diagnosis and Management of Neurofibromatosis Type 1
K Ina Ly, Jaishri O Blakeley
Continuum (Minneapolis, Minn.)
|
December 5, 2017
Common Histologically Benign Tumors of the Brain
Roy E Strowd, Jaishri O Blakeley
Neuro-Oncology
|
October 10, 2024
Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib
Scott R Plotkin, Jaishri O Blakeley
Current Treatment Options in Oncology
|
October 13, 2006
Management of pineal region tumors
Jaishri O Blakeley, Stuart A Grossman
Current Neurology and Neuroscience Reports
|
November 22, 2021
Brain Cancers in Genetic Syndromes
Edina Komlodi-Pasztor, Jaishri O Blakeley
Neuro-Oncology
|
February 7, 2016
Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis
Jaishri O Blakeley, Scott R Plotkin
Journal of the Neurological Sciences
|
July 10, 2007
Thrombolytic therapy for acute ischemic stroke
Jaishri O Blakeley, Rafael H Llinas
The British Journal of Dermatology
|
December 20, 2023
Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1
Carlos G Romo, Kavita Y Sarin, Jaishri O Blakeley
Seminars in Oncology
|
May 15, 2016
Cutaneous manifestations in neuro-oncology: clinically relevant tumor and treatment associated dermatologic findings
Roy E Strowd, Lindsay C Strowd, Jaishri O Blakeley
Page
of 14